Haemonetics Sets Date for Investor/Analyst Meeting - May 19, 2015

News provided by

Mar 24, 2015, 04:01 ET

BRAINTREE, Mass., March 24, 2015 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced today that it will host its annual investor and analyst meeting on Tuesday, May 19^th from 9:00 am to 2:30 pm at The State Room, 60 State Street in Boston, Massachusetts.

The agenda for the meeting includes updates on the following:

Current Growth Drivers: Plasma/TEG^®/Emerging Markets
Future Growth Drivers: BloodTrack^® HaemoBank™/Integrated Software Solutions/Device Connectivity
R&D Update: New Products
Comprehensive Blood Management Solutions (CBMS)
Value Creation & Capture ("VCC") and Value Engineering Initiatives
FY16 Guidance
Product Displays and Breakout Sessions With Management

The meeting is open to analysts, shareholders, and others in the investment community by invitation. Invitations will follow shortly and attendees must register by May 1^st. On-line registration will be utilized and instructions for registration will accompany invitations. Attendees are encouraged to allow sufficient time to view product displays, which will be available beginning at 9:00am and remain open until the end of the meeting.

Other audiences are welcome to participate in the meeting via live webcast. Webcast details will be posted on the Investor Relations page of our website, www.haemonetics.com. For more information, please contact Bryanne Salmon at (781) 356-9613 or [email protected].

Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing innovative blood management solutions for our customers. Together, our devices and consumables, information technology platforms, and consulting services deliver a suite of business solutions to help our customers improve patient care and reduce the cost of healthcare for blood collectors, hospitals, and patients around the world. Our technologies address important medical markets: blood and plasma component collection, the surgical suite, and hospital transfusion services. To learn more about Haemonetics, visit our web site at http://www.haemonetics.com.

CONTACT: Investor Relations
Gerry Gould (781) 356-9402
[email protected]
Bryanne Salmon (781) 356-9613
[email protected]

Logo - http://photos.prnewswire.com/prnh/20150128/172006LOGO

SOURCE Haemonetics Corporation